Motoko Kanno

11PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 21, 2026
Impact of lymphovascular space invasion on lymph node metastasis in low-grade endometrial cancer with shallow myometrial invasion and negative imaging.

|Apr 09, 2026
Prevalence and clinicopathologic features of mismatch repair-deficient endometrial cancer in Japanese patients younger than 50 years: a single-center prospective observational study.

Hidetaka Nomura, Akiko Abe, Atsushi Fusegi

|Mar 30, 2026
Effect of first-line poly(ADP-ribose) polymerase inhibitor on second-line platinum-based chemotherapy in epithelial ovarian cancer.

Yusuke Toyohara, Mayu Yunokawa, Ryo Nimura

|Jan 28, 2026
Surgical Timing and Survival in Advanced High-Grade Serous Ovarian Cancer in the PARP Inhibitor Era.

Motoko Kanno, Atsushi Fusegi, Naoki Miyazaki

|Mar 28, 2025
The impact of cytoreductive surgery on outcomes in high tumor burden ovarian cancer after induction of PARP inhibitors.

Motoko Kanno, Mayu Yunokawa, Atsushi Fusegi

|Dec 06, 2024
The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience.

Mayu Yunokawa, Akiko Abe, Xiaofei Wang

Pageof 2

Frequent Collaborators

10 joint publications

Mayu Yunokawa

10 joint publications

Hiroyuki Kanao

8 joint publications

Atsushi Fusegi

7 joint publications

Makiko Omi